Say No to Drug Ads Act

Bill: 113-hr-923
Sponsor: full_name: Rep. Nadler, Jerrold [D-NY-10]
Introduced: 2013-02-28
Policy area: Taxation
Subjects: Business expenses

Income tax deductions

Marketing and advertising

Prescription drugs
Latest action: action_date: 2013-02-28
text: Referred to the House Committee on Ways and Means.

Summaries:
action_date: 2013-02-28
action_desc: Introduced in House
text: <p>Say No to Drug Ads Act - Amends the Internal Revenue Code to deny a tax deduction for the cost of direct-to-consumer advertisement of a prescription drug. </p>

tv_txt: I 113th CONGRESS 1st Session H. R. 923 IN THE HOUSE OF REPRESENTATIVES February 28, 2013 Mr. Nadler introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs.

1. Short title This Act may be cited as the Say No to Drug Ads Act . 2. Disallowance of deduction for direct-to-consumer advertisement of prescription drugs (a) General rule Part IX of subchapter B of chapter 1 of the Internal Revenue Code of 1986 (relating to items not deductible) is amended by adding at the end the following new section: 280I. Direct-to-consumer advertisement of prescription drugs No deduction shall be allowed under this chapter for any amount paid or incurred for a direct-to-consumer advertisement of a prescription drug. . (b) Clerical amendment The table of sections for part IX of subchapter B of chapter 1 of such Code is amended by adding at the end thereof the following new item: Sec. 280I. Direct-to-consumer advertisement of prescription drugs. . (c) Effective date The amendments made by this section shall apply to amounts paid or incurred after December 31, 2013.